BridgeMD
New treatment option for Transtibial Amputation
Official title Clinical Evaluation of the Access Socket Flexible Socket for Transtibial Prosthesis
ClinicalTrials.gov ID: NCT07592325
What this study is testing
- What it's testing
- Transtibial amputation significantly impacts patient autonomy and quality of life, primarily due to the limitations of conventional rigid sockets, which restrict comfort and joint range of motion. The Access Socket (AS) is an innovative prosthetic socket combining a rigid carbon-fiber structure in key load-bearing areas with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets.
- Time commitment: about 4 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Unilateral or bilateral transtibial amputation
- Currently fitted with a definitive carbon rigid socket
- Any residual-limb shape
- Any etiology
- Able to understand simple instructions, read, write, and provide informed consent - or able to be accompanied by a trusted person in case of...
You likely can't join if
- Use of hydroalcoholic solution (HAS) for socket donning
- Currently fitted with a provisional socket
- Neurological pathology limiting capacity to participate in activities
- Orthopedic pathology limiting capacity to participate in activities
- Pregnant or breastfeeding women
- Minors
See the full eligibility criteria
- Unilateral or bilateral transtibial amputation
- Currently fitted with a definitive carbon rigid socket
- Any residual-limb shape
- Any etiology
- Able to understand simple instructions, read, write, and provide informed consent - or able to be accompanied by a trusted person in case of inability to read/write autonomously
- Provided free written informed consent
- Aged 18 years or older
- Affiliated to a social security system
- Use of hydroalcoholic solution (HAS) for socket donning
- Currently fitted with a provisional socket
- Neurological pathology limiting capacity to participate in activities
- Orthopedic pathology limiting capacity to participate in activities
- Pregnant or breastfeeding women
- Minors
- Persons not under legal protection or unable to express consent
- Persons under guardianship or curatorship
- Persons under judicial protection
The study team makes the final eligibility decision.
Where it's taking place
- Clamart, France
- Freyming-Merlebach, France
- Grenoble, France
- Nancy, France
- Paris, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Clamart, France; Freyming-Merlebach, France; Grenoble, France; Nancy, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.